Abiopharma

🔍 Viana Madeira Andre (Director)

Company: Vale S.A. (VALE)

Report Date: 2026-07-01

Detailed Transactions and Holdings:

• Acquired 1 shares of Common Shares at $15.02 per share (Direct)
  Date: 2026-07-01 | Code: P | equity_swap_involved: 0 | shares_owned_after: 71.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 1 shares of Common Shares at $15.06 per share (Direct)
  Date: 2026-07-02 | Code: P | equity_swap_involved: 0 | shares_owned_after: 72.00 | transaction_form_type: 4 | Footnotes: F2
• Acquired 5 shares of Common Shares at $14.63 per share (Direct)
  Date: 2026-08-03 | Code: P | equity_swap_involved: 0 | shares_owned_after: 77.00 | transaction_form_type: 4 | Footnotes: F3
• Acquired 4 shares of Common Shares at $14.99 per share (Direct)
  Date: 2026-08-04 | Code: P | equity_swap_involved: 0 | shares_owned_after: 81.00 | transaction_form_type: 4 | Footnotes: F4

Footnotes:

• F1: For purposes of this Form 4, a conversion rate of BRL 5.1944 for each USD 1.00 was used.
• F2: For purposes of this Form 4, a conversion rate of BRL 5.1939 for each USD 1.00 was used.
• F3: For purposes of this Form 4, a conversion rate of BRL 5.0717 for each USD 1.00 was used.
• F4: For purposes of this Form 4, a conversion rate of BRL 5.1047 for each USD 1.00 was used.